Yahoo España Búsqueda web

Search results

  1. en.wikipedia.org › wiki › Andrew_ReganAndrew Regan - Wikipedia

    Andrew Regan (born 14 December 1965, in Manchester, England) is a British-born polar explorer and entrepreneur. He is the chief executive officer of Corvus Capital, an investment company.

  2. Dr Andrew Regan is a Swiss based British born polar explorer and entrepreneur (born 14 December 1965, Manchester, England). He is the founder and Chief Executive Officer of Corvus Capital, an international investment Company.

  3. Dr Andrew Regan is a British entrepreneur and a fellow of the Royal Geographical Society. He is the CEO of Corvus Capital, a venture capital firm, and a bio-inspired algorithm researcher. He has also led several expeditions to the Arctic and Antarctic and set world records.

  4. 21 de nov. de 2011 · Andrew Regan is back. The controversial (cough, cough) businessman has struck a deal on Monday that will see him acquire a block of shares in the London Metal Exchange. His vehicle, Corvus...

  5. The Team. Corvus have extensive industry knowledge and experience across a broad range of sectors. Dr. Andrew Regan. Chief Executive Officer. Learn More. Jamie Bligh. Partner. Learn More. Lucius Raggett. Associate. Learn More. Kathy Paraskevopoulos. Executive Assistant. Learn More. Get in touch. info@corvuscapital.com. . Outlook Login. .

  6. 6 de abr. de 2023 · Andrew Regan was convicted of raping a woman in 2009 and sentenced to 12 years in prison, but the New York Court of Appeals ruled that his constitutional right to prompt prosecution was violated by the four-year delay. The court found that prosecutors failed to explain the reasons for the delays and vacated the conviction, expunging his record.

  7. 29 de abr. de 2024 · Andrew Regan is the founder of Conduit Pharmaceuticals Ltd. (founded in 2019) and Corvus Capital Ltd. (founded in 2008), where he held the title of Chief Executive Officer. He is currently the Chief Executive Officer of Corvus Capital, Inc. since 2004 and a Director at Conduit Pharmaceuticals, Inc. since 2023.